Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
267
datasets available to search
ShareScore release 0.9.0
Dataset results
267 results for “Biliary tract cancer”
Early-stage Detection of LIver, Biliary TRAct and PancReatic Cancers
ClinicalTrials.gov study NCT06139042. IPD Sharing: NO. Countries: 1. Publications: 0.
A Single-Arm Phase II Exploratory Clinical Study of Pemigatinib in the Treatment of Advanced Gastrointestinal Cancer (Excluding Biliary Tract Cancer) Patients With FGFR Alterations Who Have Failed Sta
ClinicalTrials.gov study NCT05559775. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
MicroRNA markers for the diagnosis of pancreatic and biliary tract cancers
GEO Series GSE59856. Homo sapiens. 571 samples. Type: Non-coding RNA profiling by array.
Anti-cancer effect and gene modulation of ET-743 in human biliary tract carcinoma preclinical models
GEO Series GSE63043. Homo sapiens. 8 samples. Type: Expression profiling by array.
Sphere cultured biliary tract cancer cell lines SNU245 and SNU1196
GEO Series GSE233893. Homo sapiens. 8 samples. Type: Expression profiling by array.
Study of Varlitinib Plus Capecitabine in Patients With Advanced or Metastatic Biliary Tract Cancer
ClinicalTrials.gov study NCT03129074. IPD Sharing: NO. Countries: 0. Publications: 0.
Blood Proteins in Finding Pancreatic Cancer and Extrahepatic Biliary Tract Cancer
ClinicalTrials.gov study NCT00559598. IPD Sharing: Not stated. Countries: 0. Publications: 0.
HAIC+Adebrelimab+Lenvatinib for Conversion Treatment of Potentially Resectable, Locally Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT06389500. IPD Sharing: NO. Countries: 0. Publications: 0.
A Single-arm, Open-label, Prospective Clinical Study of Surufatinib Combined With Immunotherapy and Chemotherapy for Unresectable or Metastatic Biliary Tract Cancer.
ClinicalTrials.gov study NCT06654947. IPD Sharing: NO. Countries: 0. Publications: 0.
Multicenter Phase 2 Study of Envafolimab in Biliary Tract Cancers
ClinicalTrials.gov study NCT04910386. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
A Post-marketing Observational Study of Tasfygo in Participants With Unresectable Biliary Tract Cancer With Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion Gene Positivity Who Progressed After Chem
ClinicalTrials.gov study NCT06793709. IPD Sharing: YES. Countries: 1. Publications: 0.
Pamiparib and Low Dose Temozolomide In Patients With Platinum Sensitive Biliary Tract Cancer
ClinicalTrials.gov study NCT04796454. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Combination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract Cancer
ClinicalTrials.gov study NCT06134193. IPD Sharing: NO. Countries: 0. Publications: 0.
Trastuzumab Rezetecan Combined With Pertuzumab and Iparomlimab and Tuvonralimab for Biliary Tract Cancer
ClinicalTrials.gov study NCT07129018. IPD Sharing: NO. Countries: 0. Publications: 0.
An Expanded Access Treatment Protocol of Zanidatamab (ZW25) in Patients With HER2-Positive Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT04578444. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Envafolimab With Chemotherapy and Simvastatin in Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT07003815. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Phase II Trial of Organoid Drug Sensitivity Testing to Guide Therapy in Unresectable Biliary Tract Cancers
ClinicalTrials.gov study NCT07351591. IPD Sharing: NO. Countries: 0. Publications: 0.
Safety and Tolerability Study of Nivolumab and Cabiralizumab for Resectable Biliary Tract Cancer
ClinicalTrials.gov study NCT03768531. IPD Sharing: NO. Countries: 0. Publications: 0.
Combination of Targeted and Immunotherapy for Advanced Biliary Tract and Esophagogastric Gastric Cancer
ClinicalTrials.gov study NCT03818997. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Molecular Profiling of Advanced Biliary Tract Cancers
ClinicalTrials.gov study NCT03419247. IPD Sharing: NO. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.